A Study on the Safety and Effectiveness of Endoscopic Intracavitary Submucosal Dissection for Gastric Extracavitary-Type Submucosal Tumors
1 other identifier
observational
20
0 countries
N/A
Brief Summary
The aim of this study is to explore the safety and efficacy of endoscopic surgery in the treatment of extraluminal growing stromal tumors
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
January 3, 2026
CompletedFirst Posted
Study publicly available on registry
January 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
January 13, 2026
January 1, 2026
12 months
January 3, 2026
January 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Complete resection rate
Complete resection rate of extraluminal growing stromal tumors
12 months
Secondary Outcomes (1)
Recurrence-free survival
12 months
Study Arms (1)
Endoscopic-surgery Group
Patients with extraluminal growing stromal tumors undergoing endoscopic treatment
Interventions
To observe the safety and efficacy of endoscopic treatment of extraluminal growing stromal tumors
Eligibility Criteria
Patients with gastric stromal tumor with extraluminal growth
You may qualify if:
- (1) CT scan showed extramural protrusion of the stomach (2) ultrasonic endoscopy revealed submucosal tumors with extra-gastric growth; (3) patients received ESD/EFTR or surgical treatment
You may not qualify if:
- (1) patients had malignant tumors in the stomach or had undergone stomach surgery (2) follow-up records were incomplete.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zhongda Hospitallead
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 3, 2026
First Posted
January 13, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
December 12, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
January 13, 2026
Record last verified: 2026-01